For men newly diagnosed with localized prostate cancer, estimated life expectancy is a key factor in choosing from treatment options that range from surgery and radiation to watchful waiting. For men with low- or intermediate-risk prostate cancer (based on tumor… Read More ›
Men should be fully informed that they’re unlikely to benefit from prostate cancer screening and may face a substantial risk of various harms, such as complications from biopsy or treatment that may include infection, incontinence, or impotency, according to a… Read More ›
People worried about the effects of workplace stress on their health can probably relax on one count: research appearing today in BMJ suggests that work-related stress is unlikely to be an important risk factor for cancer. About 90% of cancers… Read More ›
Many people are aware that when an individual develops cancer, especially an early-onset cancer, that event often signals that family members may have a hereditary risk for the malignancy. Now, new research underscores that the appearance of cancer later in… Read More ›
The rate of prostate cancer screening by testing prostate-specific antigen (PSA) levels among men age 75 years or older declined just 2 percentage points after a 2008 recommendation from the US Preventive Services Task Force (USPSTF) to discontinue such screening… Read More ›
Chemotherapy may induce changes in healthy cells that protect nearby tumors from the effects of such treatment, according to a study published in Nature Medicine Sunday. This discovery came as a surprise to the researchers who were probing the molecular… Read More ›
Cancer rates worldwide are expected to increase by 75% by 2030, according to the first analysis to examine global cancer patterns according to individual countries’ development levels. In some of the world’s poorest countries, the analysis indicates that cancer rates… Read More ›
An emerging type of radiation therapy for treating localized prostate cancer called proton therapy appears to be no better in reducing the risk of disease recurrence than the current standard of radiotherapy care, intensity-modulated radiation therapy (IMRT), but it is… Read More ›
Circumcised men have a lower risk of developing prostate cancer compared with uncircumcised men, according to study findings published today in the journal Cancer. This latest finding adds to the list of possible health benefits of the procedure. A growing… Read More ›
A new study finds that annual population-wide screening for prostate cancer using serum prostate-specific antigen (PSA) testing does not reduce the risk of prostate cancer death, giving further ammunition to those arguing against such screening. The study appears online today… Read More ›
